CME Group (CME) AI Stock Analysis

CME Group

(BMV:CME)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Diversified trading growthRecord volume growth across every major asset class demonstrates broad client demand rather than dependence on one market. This diversification supports durable transaction-fee revenue, strengthens CME’s liquidity network, and gives the company multiple avenues for continued activity over the next several quarters.

Negative Factors

Revenue growth decelerationSlower top-line growth indicates CME may be entering a more mature and normalized expansion phase after stronger prior years. If this persists, it could moderate operating leverage and limit the pace at which new products, market data, and international activity translate into incremental earnings.

CME Group (CME) vs. SPDR S&P 500 ETF (SPY)

Market Cap: MXN 108.50B
Dividend Yield: 3.19%
Average Volume (3M): 701
Price to Earnings (P/E): 24.7
Beta (1Y): -0.13
Revenue Growth: -2.37%
EPS Growth: 6.65%
Country: Mexico
Employees: 3,875
Sector: Financial
Sector Strength: 68
Industry: Financial - Data & Stock Exchanges

CME Group Business Overview & Revenue Model

Company Description

CME Group Inc., through its various subsidiaries, manages international marketplaces for the exchange of futures and options on futures contracts worldwide. Its extensive array of product offerings includes futures and options linked to a broad spect...

CME Group Earnings Call Summary

Earnings Call Date:Oct 20, 2026(Q3-2026)|% Change Since:8.38%|Next Earnings Date:Feb 09, 2027

Earnings Call SentimentPositive

The call was strongly positive, led by record third-quarter volume, revenue, market data, international activity, earnings, open interest, capital efficiency, retail acquisition, and shareholder returns. Management also highlighted broad product innovation, cloud and clearing initiatives, strong client demand, and multiple growth opportunities. The main negatives were regulatory uncertainty around Compute Futures and perpetuals, the withdrawal of the 24/7 WTI filing, lower clearing-house balances affecting net interest income, and several initiatives that remained in early or ramp-up stages. Overall, the highlights significantly outweighed the lowlights.

Positive Updates

Record Third-Quarter Trading Volume

Third-quarter average daily volume reached 29.4 million contracts, the highest third-quarter average daily volume in CME Group's history and up 16% year over year. Growth was broad-based, with double-digit year-over-year volume growth in all six asset classes; financial and commodity products each grew 16%.

Negative Updates

Regulatory Timing Uncertainty for Compute Futures

The CFTC extended the comment period for Compute Futures by another 45 days, ending on or about November 9, after which the agency must decide how to proceed. Management said the timing remained unknown and that CME could not move forward until receiving government approval.

Company Guidance

Management said it is on track for the December 7 launch of CME Securities Clearing, expects to begin migrating its markets to Google Cloud in late 2027, and expects the October 1 pricing changes to have an annualized impact of somewhere in the range of 0.5%-1% of clearing and transaction fees; the Cboe licensing agreement may provide increases starting in 2027, not 2032, while firms are targeting Q4 to be fully up and running for CME FICC Cross Margining, which is expected to have a ramp-up period. As the company enters the fourth quarter, volume is surpassing last year's record fourth quarter by 17%, it is tracking 12% ahead of last year's record volume year-to-date, and management remains firmly on track to deliver another record year, but said there is no fundamental change in the outlook and it does not share specific expectations about future market data growth.

CME Group Risk Analysis

CME Group disclosed 28 risk factors in its most recent earnings report. CME Group reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

CME Group Peers Comparison

Overall Rating

UnderperformOutperform

Sector (68)

Financial Indicators

MX:CME against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ICE	83Outperform	$94.36B	22.94	14.08%	1.21%	13.51%	33.41%
CBOE	80Outperform	$35.04B	23.81	26.84%	0.90%	14.31%	50.84%
NDAQ	79Outperform	$58.95B	28.71	17.29%	1.09%	11.94%	30.40%
SPGI	79Outperform	$135.25B	27.74	17.54%	0.83%	5.99%	22.20%
Sector *	68Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
COIN	56Neutral	$38.00B	-54.79	-5.08%	―	-47.61%	-120.69%

* Financial Sector Average

Performance Comparison

MX:CME and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
MX:CME	CME Group Inc	5757.00	1062.83	22.64%
CBOE	Cboe Global Markets	335.53	91.10	37.27%
ICE	Intercontinental Exchange Inc.	168.85	25.17	17.52%
SPGI	S&P Global	466.55	0.58	0.13%
NDAQ	Nasdaq OMX	106.23	20.97	24.59%
COIN	Coinbase Global, Inc.	143.54	-186.88	-56.56%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

CME Group AI Stock Analysis